These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 26022202)

  • 1. Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings.
    Doi Y; Kanagawa M; Maya Y; Tanaka A; Oka S; Nakata N; Toyama M; Matsumoto H; Shirakami Y
    Nucl Med Biol; 2015 Aug; 42(8):664-72. PubMed ID: 26022202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
    Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
    Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase IIa clinical study of [
    Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H
    Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.
    Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
    Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas.
    Karlberg A; Berntsen EM; Johansen H; Skjulsvik AJ; Reinertsen I; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
    Clin Nucl Med; 2019 Jul; 44(7):550-559. PubMed ID: 31107743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) accumulation in lymph node prostate cancer metastasis and lymphadenitis in rats.
    Kanagawa M; Doi Y; Oka S; Kobayashi R; Nakata N; Toyama M; Shirakami Y
    Nucl Med Biol; 2014 Aug; 41(7):545-51. PubMed ID: 24816330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of anti-3-[
    Karlberg A; Pedersen LK; Vindstad BE; Skjulsvik AJ; Johansen H; Solheim O; Skogen K; Kvistad KA; Bogsrud TV; Myrmel KS; Giskeødegård GF; Ingebrigtsen T; Berntsen EM; Eikenes L
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):496-509. PubMed ID: 37776502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma.
    Ono T; Sasajima T; Doi Y; Oka S; Ono M; Kanagawa M; Baden A; Mizoi K; Shimizu H
    Nucl Med Biol; 2015 Jul; 42(7):598-607. PubMed ID: 25892210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Bevacizumab on Blood-Brain Barrier Permeability and
    Stegmayr C; Oliveira D; Niemietz N; Willuweit A; Lohmann P; Galldiks N; Shah NJ; Ermert J; Langen KJ
    J Nucl Med; 2017 May; 58(5):700-705. PubMed ID: 28153956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
    Pafundi DH; Laack NN; Youland RS; Parney IF; Lowe VJ; Giannini C; Kemp BJ; Grams MP; Morris JM; Hoover JM; Hu LS; Sarkaria JN; Brinkmann DH
    Neuro Oncol; 2013 Aug; 15(8):1058-67. PubMed ID: 23460322
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F
    Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer.
    Oka S; Hattori R; Kurosaki F; Toyama M; Williams LA; Yu W; Votaw JR; Yoshida Y; Goodman MM; Ito O
    J Nucl Med; 2007 Jan; 48(1):46-55. PubMed ID: 17204698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.
    Shoup TM; Olson J; Hoffman JM; Votaw J; Eshima D; Eshima L; Camp VM; Stabin M; Votaw D; Goodman MM
    J Nucl Med; 1999 Feb; 40(2):331-8. PubMed ID: 10025843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
    Turkbey B; Mena E; Shih J; Pinto PA; Merino MJ; Lindenberg ML; Bernardo M; McKinney YL; Adler S; Owenius R; Choyke PL; Kurdziel KA
    Radiology; 2014 Mar; 270(3):849-56. PubMed ID: 24475804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
    Oka S; Okudaira H; Ono M; Schuster DM; Goodman MM; Kawai K; Shirakami Y
    Mol Imaging Biol; 2014 Jun; 16(3):322-9. PubMed ID: 24136390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
    Hutterer M; Nowosielski M; Putzer D; Jansen NL; Seiz M; Schocke M; McCoy M; Göbel G; la Fougère C; Virgolini IJ; Trinka E; Jacobs AH; Stockhammer G
    Neuro Oncol; 2013 Mar; 15(3):341-51. PubMed ID: 23335162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal
    Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
    World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of blood-brain barrier permeability on O-(2-
    Stegmayr C; Bandelow U; Oliveira D; Lohmann P; Willuweit A; Filss C; Galldiks N; Lübke JH; Shah NJ; Ermert J; Langen KJ
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):408-416. PubMed ID: 27613541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.